Literature DB >> 19901433

Cervical cancer screening & HPV vaccination: a comprehensive approach to cervical cancer control.

Partha Basu1, Debjani Chowdhury.   

Abstract

India with its highest share of global burden of cervical cancer has to implement a population based cervical cancer control program to reduce the number of deaths. There are new screening options available like visual inspection after acetic acid application (VIA) test, single visit approach to screening and treatment etc. Emergence of the two effective vaccines against human papillomavirus (HPV), the necessary cause of cervical cancer, has introduced a fresh lease of life to the cervical cancer control strategies. The current high cost of the vaccines is a major impediment to implement a vaccine-based primary prevention approach.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901433

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  9 in total

Review 1.  Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness.

Authors:  I Mattheij; A M Pollock; P Brhlikova
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles.

Authors:  N Hanumantha Rao; P Baji Babu; L Rajendra; R Sriraman; Yuk-Ying S Pang; John T Schiller; V A Srinivasan
Journal:  Vaccine       Date:  2011-07-29       Impact factor: 3.641

3.  Acceptability of HPV vaccine implementation among parents in India.

Authors:  Proma Paul; Amanda E Tanner; Patti E Gravitt; K Vijayaraghavan; Keerti V Shah; Gregory D Zimet; Catch Study Group
Journal:  Health Care Women Int       Date:  2013-04-23

4.  Girdin expression in cervical carcinoma and its role in the malignant properties of HeLa cells.

Authors:  Ping Jiang; Ya-Li Ren; Jia-Liang Li; Jun Luo
Journal:  Oncol Lett       Date:  2016-02-18       Impact factor: 2.967

5.  PARP-1 Val762Ala polymorphism is associated with risk of cervical carcinoma.

Authors:  Feng Ye; Qi Cheng; Yuting Hu; Jing Zhang; Huaizeng Chen
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

6.  Is existing cervical cancer screening proven productive in developing nations: Time to move from the laboratory to community?

Authors:  Sandeep Singh; Sorabh Badaya; Manish Kishore Multani
Journal:  South Asian J Cancer       Date:  2013-10

7.  A strategy to increase the uptake of cervical cancer screening in India: A lesson from the ongoing programs.

Authors:  Sandeep Singh; Sorabh Badaya
Journal:  South Asian J Cancer       Date:  2013-10

8.  Community Awareness of HPV Screening and Vaccination in Odisha.

Authors:  Niharika Khanna; Aparna Ramaseshan; Stephanie Arnold; Kalpana Panigrahi; Mark D Macek; Bijaya K Padhi; Diptirani Samanta; Surendra N Senapati; Pinaki Panigrahi
Journal:  Obstet Gynecol Int       Date:  2015-12-09

9.  Sexual Dysfunction in Females after Cancer Treatment: an Unresolved Issue

Authors:  Abhishek Shankar; Shubham Roy; Abhijit Chakraborty; Aalekhya Sharma Biswas; Jaineet Patil; Goura Kishor Rath
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.